Larimar Therapeutics Inc (LRMR)
8.19
-1.20
(-12.78%)
USD |
NASDAQ |
Jun 17, 15:25
Larimar Therapeutics Accounts Payable (Quarterly): 1.918M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.918M |
| December 31, 2023 | 1.283M |
| September 30, 2023 | 0.756M |
| June 30, 2023 | 2.344M |
| March 31, 2023 | 0.695M |
| December 31, 2022 | 1.686M |
| September 30, 2022 | 0.849M |
| June 30, 2022 | 0.425M |
| March 31, 2022 | 2.417M |
| Date | Value |
|---|---|
| December 31, 2021 | 1.66M |
| September 30, 2021 | 1.766M |
| June 30, 2021 | 1.463M |
| March 31, 2021 | 3.23M |
| December 31, 2020 | 2.634M |
| September 30, 2020 | 1.269M |
| June 30, 2020 | 2.258M |
| December 31, 2019 | 3.539M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.425M
Minimum
Jun 2022
3.539M
Maximum
Dec 2019
1.776M
Average
1.686M
Median
Dec 2022
Accounts Payable (Quarterly) Benchmarks
| Biogen Inc | 387.00M |
| Eli Lilly and Co | 2.474B |
| PTC Therapeutics Inc | 27.46M |
| Design Therapeutics Inc | 1.372M |
| CEL-SCI Corp | 1.016M |